HOME>Investor Relations>FAQ

FAQ

About the company

When did Mitsubishi Tanabe Pharma Corporation come into being?
Mitsubishi Tanabe Pharma Corporation came into being on October 1, 2007, through the merger of Tanabe Seiyaku Co., Ltd., and Mitsubishi Pharma Corporation. To find out more about the company’s history, see here. Link to Corporate History page
Where can I find out about your corporate policies and future vision?
To mark the creation of Mitsubishi Tanabe Pharma Corporation, we have established a Corporate Philosophy, a Target Profile, a logo, and a set of Management Targets for the new company. To view these, follow this link.
In November 2015, the Company has formulated "the Medium-Term Management Plan 16-20 : Open Up the Future". Link to"the Medium-Term Management Plan 16-20 : Open Up the Future"
What is your relationship with Mitsubishi Chemical Holdings Corporation?
Mitsubishi Chemical Holdings Corporation was established on October 3, 2005, as a joint holding company exercising full ownership of the shares of one of our predecessor companies, such as Mitsubishi Pharma Corporation and Mitsubishi Chemical Corporation.
Today, it is our consolidated parent company and controls 56.3% of our shares. In addition to playing our role as a core company in the healthcare segment of the Mitsubishi Chemical Holdings Group, we are committed as a listed company to pursuing independently determined business policies for the maximum benefit of our shareholders.
To view the Corporate Outline of Mitsubishi Chemical Holdings Corporation, see here. Link to Corporate Outline of Mitsubishi Chemical Holdings Corporation

Top of Page

About our shares

Which stock exchanges in Japan are your shares listed on?
Tokyo and Osaka.
What is your Securities Code?
4508
What is the trading unit for your shares?
100 shares.
Do you have a special benefit program for shareholders?
No, we do not have such a program.
At what time of year do you pay dividends?
Our interim dividend is paid in early December and our year-end dividend in late June.
When is the date of record for shareholders to receive payment of dividends?
September 30 for the interim dividend and March 31 for the year-end dividend.
What are the dates of your business year?
Our business year runs from April 1 to March 31 of the following year.
Please see our IR calendar for a schedule of the publication of business results, where details are posted as soon as decisions are made(*1)
What is the date of your annual general meeting of shareholders?
The meeting is held in June each year.
For the exact date see our IR calendar, where it is posted once the date is fixed.
Who should I contact for administrative matters relating to shares (change of name or address, receiving dividends, etc.)?
These matters are handled by the Mitsubishi UFJ Trust and Banking Corporation, who act as our share transfer and register agent. For details visit their website at http://www.tr.mufg.jp/daikou or contact the Telephone Center of their Securities Agency Department.
  • 7-10-11 Higashisuna, Koutou-ku, Tokyo 137-8081 Tel: 0120-232-711
  • 1-7-7 Nishi-Ikebukuro, Toyoshima-ku, Tokyo 171-8508 Tel: 0120-707-696
  • 1-1-5 Dojimahama, Kita-ku, Osaka 530-0004 Tel: 0120-094-777
  • 3-21-24 Nishiki, Naka-ku, Nagoya 460-8660 Tel:0120-232-711
To receive an application form, contact one of the centers below (telephone calls handled by automatic voice recognition system)
  • 7-10-11 Higashisuna, Koutou-ku, Tokyo 137-8081 Tel: 0120-244-479
  • 1-7-7 Nishi-Ikebukuro, Toyoshima-ku, Tokyo 171-8508 Tel: 0120-864-490
  • 1-1-5 Dojimahama, Kita-ku, Osaka 530-0004 Tel: 0120-684-479

Top Of Page

About our accounts and finances

Where can I find out about the business performance of Mitsubishi Tanabe Pharma Corporation?
See here for information on our business results, see here for our Financial Statement Report, and see here for other Investor Relations information.
How do I get a copy of your company annual report?
You can view the annual reports of our predecessor companies (Tanabe Seiyaku and Mitsubishi Pharma Corporation) on this website (HTML, PDF). The annual report of Mitsubishi Tanabe Pharma Corporation is due to appear in summer 2008.

Top Of Page

This website was created and is operated by Mitsubishi Tanabe Pharma Corporation (Mitsubishi Tanabe Pharma). Please take note of the points set out below when using the website.

About links

We provide links to other sites for the convenience of website users. Users who access the linked sites should note that such sites are completely independent of this website and that we have no control over their content.
The provision of links to other sites does not constitute a recommendation by us of the use or the content of the relevant websites nor an acceptance of responsibility in connection with such websites.
As a matter of general policy, this website does not accept new reciprocal links and is not free to link to.

Investor Relations

Share Price Information

ReadSpeaker docReader makes documents accessible to all users including users with vision problems letting users view and listen to texts.
User guide